Imino(methyl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-l6-sulfanone, 5g

EDC hydrochloride, 99.0%, 100g

1-Benzyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 1g

6-(2,2,2-Trifluoroethyl)-1h-thieno[2,3-d]pyrimidine-2,4-dione, 98%, 250mg

4-((5-Aminopentyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 2,2,2-trifluoroacetate, 97%, 100mg

(S)-4-(6-(3,5-Dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo[3,2-b]pyridin-3-yl)benzoic acid, 98.00%, 1mg

2-(4-Chlorophenoxy)benzaldehyde>98.0%(GC)1g

4-Ethylbenzenethiol, 97% +total of isomer, 100g

1,1-Dimethyl-4-oxopiperidin-1-ium iodide, 95.0%, 25g

4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid, 97.0%, 10g

(4-Methylpyridin-3-yl)methanol, 97.0%, 10g

4-(Trifluoromethoxy)phenacyl bromide, 97.0%, 25g

2-(2-Bromophenyl)propan-2-amine hydrochloride, 95.0%, 100mg